These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 683893)

  • 21. Treatment of pulmonary infections.
    Simberkoff MS; Rahal JJ
    Compr Ther; 1976 May; 2(5):35-41. PubMed ID: 776518
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of ciprofloxacin versus amoxicillin + clavulanic acid or erythromycin for the empiric treatment of community-acquired pneumonia].
    Mouton Y; Beuscart C; Leroy O; Ajana F; Charrel J
    Pathol Biol (Paris); 1991 Jan; 39(1):34-7. PubMed ID: 2011407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of pulmonary erythromycin concentration in patients with lobar pneumonia by means of positron tomography.
    Wollmer P; Pride NB; Rhodes CG; Sanders A; Pike VW; Palmer AJ; Silvester DJ; Liss RH
    Lancet; 1982 Dec; 2(8312):1361-4. PubMed ID: 6129462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.
    Song JH; Jung SI; Ki HK; Shin MH; Ko KS; Son JS; Chang HH; Kim SW; Lee H; Kim YS; Oh WS; Peck KR; Chongthaleong A; Lalitha MK; Perera J; Yee TT; Jamal F; Kamarulzaman A; Carlos CC; So T;
    Clin Infect Dis; 2004 Jun; 38(11):1570-8. PubMed ID: 15156445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced urinary estriol levels with erythromycin therapy.
    Gallagher JC; Ismail MA; Aladjem S
    Obstet Gynecol; 1980 Sep; 56(3):381-2. PubMed ID: 7422180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
    J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of pneumococcal pneumonia.
    Pallares R
    Semin Respir Infect; 1999 Sep; 14(3):276-84. PubMed ID: 10501315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The antibacterial and chemotherapeutic activity of the Soviet produced antibiotic rifamitsina SV].
    Shorin VA; Shapovalova SP
    Antibiotiki; 1974 Jan; 19(1):3-6. PubMed ID: 4156904
    [No Abstract]   [Full Text] [Related]  

  • 29. [On some characteristics of staphylococci isolated from the sputum before and after therapy with erythromycin].
    Lo Curto RB; Pernice A; Alonzo V
    G Batteriol Virol Immunol Microbiol; 1973; 66(7-12):269-75. PubMed ID: 4802277
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of erythromycin plus lincomycin association on renal staphylococcia in mice induced by "dissociated resistant" Staphylococcus aureus].
    Bourse R; Daver J; Monnier J
    Ann Inst Pasteur (Paris); 1969 Jun; 116(6):750-9. PubMed ID: 5363514
    [No Abstract]   [Full Text] [Related]  

  • 31. Pneumonia.
    Br Med J; 1971 Sep; 3(5777):759-61. PubMed ID: 4399404
    [No Abstract]   [Full Text] [Related]  

  • 32. Lincomycin: a clinical study.
    Spitzer S; Mason D; Moyer JH
    Geriatrics; 1968 Sep; 23(9):165-8. PubMed ID: 4386268
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravitreal erythromycin in the treatment of induced staphylococcal endophthalmitis.
    Meisels HI; Peyman GA
    Ann Ophthalmol; 1976 Aug; 8(8):939-43. PubMed ID: 1085597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of staphylococcal infections in children by monomycin, neomycin, erythromycin and oletetrin].
    Balashova II; Khomiakova VI
    Antibiotiki; 1967 Sep; 12(9):849-52. PubMed ID: 5585720
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Staphylococcus aureus.
    Barg N
    J Antimicrob Chemother; 1998 Aug; 42(2):257-60. PubMed ID: 9738847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolypomycin, a new antibiotic. V. In vitro and in vivo antimicrobial activity.
    Kondo M; Oishi T; Tsuchiya K
    J Antibiot (Tokyo); 1972 Jan; 25(1):16-24. PubMed ID: 4110839
    [No Abstract]   [Full Text] [Related]  

  • 37. The relative efficacy of erythromycin (ilotycin) and of penicillin in the treatment of pneumococcal lobar pneumonia.
    AUSTRIAN R; ROSENBLUM R
    Am J Med Sci; 1953 Nov; 226(5):487-90. PubMed ID: 13104398
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.
    Witzenrath M; Schmeck B; Doehn JM; Tschernig T; Zahlten J; Loeffler JM; Zemlin M; Müller H; Gutbier B; Schütte H; Hippenstiel S; Fischetti VA; Suttorp N; Rosseau S
    Crit Care Med; 2009 Feb; 37(2):642-9. PubMed ID: 19114881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumococcal bacteraemia in south Auckland: a five year review with emphasis on prescribing practices.
    Singh KP; Voolmann T; Lang SD
    N Z Med J; 1992 Oct; 105(943):394-5. PubMed ID: 1461592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.